Increased expression of complement decay-accelerating factor during activation of human neutrophils.

Por Berger, M, Medof, M E
Publicado em 1987

Alternative pathway-mediated rebinding of immune complexes to human red blood cells.

Por Medof, M E, Prince, G M
Publicado em 1983

Immune complex alterations occur on the human red blood cell membrane.

Por Medof, M E, Prince, G M
Publicado em 1983

Ability of complement to release systemic lupus erythematosus immune complexes from cell receptors.

Por Medof, M E, Scarborough, D, Miller, G
Publicado em 1981

Differential cytokine expression of human retinal pigment epithelial cells in response to stimulation by C5a

Por FUKUOKA, Y, STRAINIC, M, MEDOF, M E
Publicado em 2003

Assembly and deacetylation of N-acetylglucosaminyl-plasmanylinositol in normal and affected paroxysmal nocturnal hemoglobinuria cells.

Por Hirose, S, Ravi, L, Hazra, S V, Medof, M E
Publicado em 1991

Characterization of the decay-accelerating factor gene promoter region.

Por Ewulonu, U K, Ravi, L, Medof, M E
Publicado em 1991

Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor.

Por Medof, M E, Kinoshita, T, Silber, R, Nussenzweig, V
Publicado em 1985

Stimulation of NK-like CMC by skin test antigens in vitro is depressed in patients with SLE.

Por Tartof, D, Check, I J, Medof, M E
Publicado em 1982

Kinetics of interaction of immune complexes with complement receptors on human blood cells: modification of complexes during interaction with red cells.

Por Medof, M E, Prince, G M, Oger, J J
Publicado em 1982

Antigen-presenting cell engineering. The molecular toolbox.

Por Tykocinski, M. L., Kaplan, D. R., Medof, M. E.
Publicado em 1996

Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients.

Por Wang, R H, Phillips, G, Medof, M E, Mold, C
Publicado em 1993

Synthesis of aberrant decay-accelerating factor proteins by affected paroxysmal nocturnal hemoglobinuria leukocytes.

Por Carothers, D J, Hazra, S V, Andreson, S W, Medof, M E
Publicado em 1990

Accumulation of glucosaminyl(acyl)phosphatidylinositol in an S3 HeLa subline expressing normal dolicholphosphomannose synthase activity.

Por Sevlever, D, Schiemann, D, Guidubaldi, J, Medof, M E, Rosenberry, T L
Publicado em 1997

Structure/function studies of human decay-accelerating factor

Por Brodbeck, W G, Kuttner-Kondo, L, Mold, C, Medof, M E
Publicado em 2000

COOH-terminal processing of nascent polypeptides by the glycosylphosphatidylinositol transamidase in the presence of hydrazine is governed by the same parameters as glycosylphospha...

Por Ramalingam, S, Maxwell, S E, Medof, M E, Chen, R, Gerber, L D, Udenfriend, S
Publicado em 1996

Heightened complement sensitivity of acquired immunodeficiency syndrome lymphocytes related to diminished expression of decay-accelerating factor.

Por Lederman, M M, Purvis, S F, Walter, E I, Carey, J T, Medof, M E
Publicado em 1989

Glycosylphosphatidylinositol-anchor intermediates associate with triton-insoluble membranes in subcellular compartments that include the endoplasmic reticulum.

Por Sevlever, D, Pickett, S, Mann, K J, Sambamurti, K, Medof, M E, Rosenberry, T L
Publicado em 1999

Stimulation of glycogen synthesis by insulin in human erythroleukemia cells requires the synthesis of glycosyl-phosphatidylinositol.

Por Lazar, D F, Knez, J J, Medof, M E, Cuatrecasas, P, Saltiel, A R
Publicado em 1994

In vitro attachment of glycosyl-inositolphospholipid anchor structures to mouse Thy-1 antigen and human decay-accelerating factor.

Por Fasel, N, Rousseaux, M, Schaerer, E, Medof, M E, Tykocinski, M L, Bron, C
Publicado em 1989